Tech startup BioOra aims to scale up and democratise blood cancer treatments

Tech startup BioOra aims to scale up and democratise blood cancer treatments
One of the machines BioOra will use to automate CAR-T cell production. (Image: BioOra/Malaghan Institute)
Greg Hurrell
New Zealand tech startup company BioOra is in the business of automating an experimental but laborious cancer therapy process now undergoing clinical trials.BioOra was specifically set up to automate the manufacture of the Malaghan Institute’s individualised treatment for some types of blood cancer.To start with, the automated process will allow more patients to be brought into the trials, but if Medsafe approves the therapy, it is on track to become a standard blood cancer therapy.While BioOra has ambitions to manufacture Malaghan’...

More Health

Health and Safety Reform: Watch the road not the cones
Opinion

Jeff Sissons: Health and Safety Reform: Watch the road not the cones

This govt and the previous one have been starving the health and safety system of funding.

Why Americans eat a sunscreen ingredient in their pizza
Health

Why Americans eat a sunscreen ingredient in their pizza

Health concerns grow over titanium dioxide, but NZ and Australia believe it's safe.

Green Cross makes healthcare a primary objective
Opinion

Paul McBeth: Green Cross makes healthcare a primary objective

Group has the country's largest general practice enrolled patient base. 

Paul McBeth 11 Jun 2024
Lung cancer was once a death sentence. Now that's changing
Health

Lung cancer was once a death sentence. Now that's changing

New drugs are holding the disease in check for months or years.